Grape King Bio Ltd (TPE:1707)
Taiwan
· Delayed Price · Currency is TWD 118.50
-2.00 (-1.66%)
Mar 9, 2026, 1:35 PM CST
Grape King Bio Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 10,252 | 11,160 | 10,635 | 10,391 | 9,798 | Upgrade
|
| Revenue Growth (YoY) | -8.14% | 4.93% | 2.35% | 6.05% | 6.87% | Upgrade
|
| Cost of Revenue | 2,555 | 2,502 | 2,099 | 1,909 | 1,942 | Upgrade
|
| Gross Profit | 7,697 | 8,658 | 8,536 | 8,482 | 7,856 | Upgrade
|
| Selling, General & Admin | 5,281 | 5,866 | 5,747 | 5,639 | 5,252 | Upgrade
|
| Research & Development | 274.66 | 291.91 | 289.55 | 289.88 | 292.23 | Upgrade
|
| Other Operating Expenses | -0.52 | 0.02 | 2.48 | 1.1 | 0.57 | Upgrade
|
| Operating Expenses | 5,555 | 6,158 | 6,039 | 5,930 | 5,544 | Upgrade
|
| Operating Income | 2,142 | 2,500 | 2,497 | 2,552 | 2,312 | Upgrade
|
| Interest Expense | -4.75 | -3.04 | -2.54 | -2.29 | -3.93 | Upgrade
|
| Interest & Investment Income | 46.15 | 49.97 | 47.6 | 19.92 | 6.29 | Upgrade
|
| Earnings From Equity Investments | 28.72 | 22.24 | 19.87 | 10.82 | 2.23 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | 11.63 | -2.24 | Upgrade
|
| Other Non Operating Income (Expenses) | 86.07 | 104.3 | 99.02 | 94.1 | 99.35 | Upgrade
|
| EBT Excluding Unusual Items | 2,298 | 2,673 | 2,661 | 2,686 | 2,413 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -1.91 | 0.8 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 3.76 | 0.82 | Upgrade
|
| Other Unusual Items | - | - | - | 0.11 | - | Upgrade
|
| Pretax Income | 2,298 | 2,673 | 2,661 | 2,688 | 2,415 | Upgrade
|
| Income Tax Expense | 436.77 | 502.15 | 519.11 | 518.19 | 466.92 | Upgrade
|
| Earnings From Continuing Operations | 1,861 | 2,171 | 2,142 | 2,170 | 1,948 | Upgrade
|
| Minority Interest in Earnings | -642.63 | -722.85 | -688.78 | -712.58 | -647.57 | Upgrade
|
| Net Income | 1,218 | 1,448 | 1,453 | 1,457 | 1,300 | Upgrade
|
| Net Income to Common | 1,218 | 1,448 | 1,453 | 1,457 | 1,300 | Upgrade
|
| Net Income Growth | -15.88% | -0.30% | -0.30% | 12.05% | 2.23% | Upgrade
|
| Shares Outstanding (Basic) | 148 | 148 | 148 | 148 | 148 | Upgrade
|
| Shares Outstanding (Diluted) | 149 | 149 | 149 | 149 | 148 | Upgrade
|
| Shares Change (YoY) | -0.02% | 0.00% | 0.06% | 0.45% | 8.41% | Upgrade
|
| EPS (Basic) | 8.22 | 9.78 | 9.81 | 9.84 | 8.81 | Upgrade
|
| EPS (Diluted) | 8.17 | 9.71 | 9.74 | 9.78 | 8.76 | Upgrade
|
| EPS Growth | -15.86% | -0.31% | -0.41% | 11.64% | -5.71% | Upgrade
|
| Free Cash Flow | 1,734 | 1,249 | 1,932 | 2,504 | 2,267 | Upgrade
|
| Free Cash Flow Per Share | 11.63 | 8.38 | 12.96 | 16.80 | 15.28 | Upgrade
|
| Dividend Per Share | - | 6.900 | 6.900 | 6.900 | 6.100 | Upgrade
|
| Dividend Growth | - | - | - | 13.11% | -4.69% | Upgrade
|
| Gross Margin | 75.08% | 77.58% | 80.26% | 81.63% | 80.18% | Upgrade
|
| Operating Margin | 20.89% | 22.40% | 23.47% | 24.56% | 23.59% | Upgrade
|
| Profit Margin | 11.88% | 12.98% | 13.66% | 14.02% | 13.27% | Upgrade
|
| Free Cash Flow Margin | 16.92% | 11.19% | 18.17% | 24.09% | 23.14% | Upgrade
|
| EBITDA | 2,698 | 3,013 | 2,956 | 2,936 | 2,679 | Upgrade
|
| EBITDA Margin | 26.32% | 27.00% | 27.80% | 28.26% | 27.34% | Upgrade
|
| D&A For EBITDA | 556.55 | 513.48 | 459.76 | 384.63 | 367.68 | Upgrade
|
| EBIT | 2,142 | 2,500 | 2,497 | 2,552 | 2,312 | Upgrade
|
| EBIT Margin | 20.89% | 22.40% | 23.47% | 24.56% | 23.59% | Upgrade
|
| Effective Tax Rate | 19.01% | 18.78% | 19.51% | 19.28% | 19.34% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.